Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Neurological Medicine
Volume 2011 (2011), Article ID 975152, 4 pages
http://dx.doi.org/10.1155/2011/975152
Case Report

Anti-Glutamic Acid Decarboxylase Antibody-Associated Ataxia as an Extrahepatic Autoimmune Manifestation of Hepatitis C Infection: A Case Report

1Baton Rouge Neurology Associates, Baton Rouge General Medical Center, Baton Rouge, LA, USA
2Department of Neurology, The University of Texas Southwestern Medical Center, Dallas, TX, USA
3Neurology Section, VA North Texas Health Care Systems, Dallas, TX, USA
4Department of Internal Medicine-Digestive and Liver Diseases, The University of Texas Southwestern Medical Center, Dallas, TX, USA
5Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH, USA
6Department of Neurology, University of Kansas Medical Center, Kansas, KS, USA

Received 23 May 2011; Accepted 15 June 2011

Academic Editors: Andrea Eugenio Cavanna, Massimiliano Filosto, and José Luis González-Gutiérrez

Copyright © 2011 Amer Awad et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Ferri, L. Muratori, M. Lenzi, A. Granito, F. B. Bianchi, and D. Vergani, “HCV and autoimmunity,” Current Pharmaceutical Design, vol. 14, no. 17, pp. 1678–1685, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Ferri, “Mixed cryoglobulinemia,” Orphanet Journal of Rare Diseases, vol. 3, no. 1, article 25, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Ramos-Casals, S. Muñoz, F. Medina et al., “Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry),” Journal of Rheumatology, vol. 36, no. 7, pp. 1442–1448, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Lormeau, G. Falgarone, D. Roulot, and M. C. Boissier, “Rheumatologic manifestations of chronic hepatitis C infection,” Joint Bone Spine, vol. 73, no. 6, pp. 633–638, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. M. M. Ahmed, S. M. Berney, R. E. Wolf et al., “Prevalence of active hepatitis C virus infection in patients with systemic lupus erythematosus,” American Journal of the Medical Sciences, vol. 331, no. 5, pp. 252–256, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Canada, S. Chaudry, L. Gaber, B. Waters, A. Martinez, and B. Wall, “Polyarteritis nodosa and cryoglobulinemic glomerulonephritis related to chronic hepatitis C,” American Journal of the Medical Sciences, vol. 331, no. 6, pp. 329–333, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. A. M. Atta, P. Estevam, R. Paraná, C. M. Pereira, B. C. O. Leite, and M. L. B. Sousa-Atta, “Antiphospholipid antibodies in Brazilian hepatitis C virus carriers,” Brazilian Journal of Medical and Biological Research, vol. 41, no. 6, pp. 489–492, 2008. View at Google Scholar · View at Scopus
  8. A. di Muzio, B. Bonetti, M. Capasso et al., “Hepatitis C virus infection and myositis: a virus localization study,” Neuromuscular Disorders, vol. 13, no. 1, pp. 68–71, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Ramos-Casals, J. Mañá, N. Nardi et al., “Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases,” Medicine (Baltimore), vol. 84, no. 2, pp. 69–80, 2005. View at Publisher · View at Google Scholar
  10. A. Antonelli, C. Ferri, S. M. Ferrari, M. Colaci, D. Sansonno, and P. Fallahi, “Endocrine manifestations of hepatitis C virus infection,” Nature Clinical Practice Endocrinology and Metabolism, vol. 5, no. 1, pp. 26–34, 2009. View at Publisher · View at Google Scholar
  11. P. Martin and F. Fabrizi, “Hepatitis C virus and kidney disease,” Journal of Hepatology, vol. 49, no. 4, pp. 613–624, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Cacoub and D. Saadoun, “Hepatitis C virus infection induced vasculitis,” Clinical Reviews in Allergy and Immunology, vol. 35, no. 1-2, pp. 30–39, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. A. J. de Almeida, M. Campos-de-Magalhães, C. L. Antonietti et al., “Autoimmune thrombocytopenia related to chronic hepatitis C virus infection,” Hematology, vol. 14, no. 1, pp. 49–58, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Ferri, A. Antonelli, M. T. Mascia et al., “B-cells and mixed cryoglobulinemia,” Autoimmunity Reviews, vol. 7, no. 2, pp. 114–120, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Victor, R. D. Adams, and E. L. Mancall, “A restricted form of cerebellar cortical degeneration occurring in alcoholic patients,” Archives of Neurology, vol. 1, no. 6, pp. 579–688, 1959. View at Google Scholar
  16. A. J. Bastian, J. W. Mink, B. A. Kaufman, and W. T. Thach, “Posterior vermal split syndrome,” Annals of Neurology, vol. 44, no. 4, pp. 601–610, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Sechi, “Prognosis and therapy of Wernicke's encephalopathy after obesity surgery,” American Journal of Gastroenterology, vol. 103, no. 12, p. 3219, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Von Drygalski and D. A. Andris, “Anemia after bariatric surgery: more than just iron deficiency,” Nutrition in Clinical Practice, vol. 24, no. 2, pp. 217–226, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Jayaram, A. Soman, S. Tarvade, and V. Londhe, “Cerebellar Ataxia due to isolated Vitamin E deficiency,” Indian Journal of Medical Sciences, vol. 59, no. 1, pp. 20–23, 2005. View at Google Scholar · View at Scopus
  20. T. W. Clarkson, “The toxicology of mercury,” Critical Reviews in Clinical Laboratory Sciences, vol. 34, no. 4, pp. 369–403, 1997. View at Google Scholar · View at Scopus
  21. M. F. Gordon, R. I. Abrams, D. B. Rubin, W. B. Barr, and D. D. Correa, “Bismuth toxicity,” Neurology, vol. 44, no. 12, p. 2418, 1994. View at Google Scholar · View at Scopus
  22. M. Hadjivassiliou, D. S. Sanders, N. Woodroofe, C. Williamson, and R. A. Grünewald, “Gluten ataxia,” Cerebellum, vol. 7, no. 3, pp. 494–498, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Sue, A. Yoshihara, T. Otani, Y. Tsuchida, M. Higa, and N. Hiroi, “Characteristics of fulminant type 1 diabetes mellitus,” Medical Science Monitor, vol. 14, no. 10, pp. 97–101, 2008. View at Google Scholar · View at Scopus
  24. M. C. Dalakas, “Advances in the pathogenesis and treatment of patients with stiff person syndrome,” Current Neurology and Neuroscience Reports, vol. 8, no. 1, pp. 48–55, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Matà, G. C. Muscas, I. Naldi et al., “Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies,” Journal of Neuroimmunology, vol. 199, no. 1-2, pp. 155–159, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Markakis, E. Alexiou, M. Xifaras, G. Gekas, and A. Rombos, “Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase,” Clinical Neurology and Neurosurgery, vol. 110, no. 6, pp. 619–621, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Vulliemoz, G. Vanini, A. Truffert, C. Chizzolini, and M. Seeck, “Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 78, no. 2, pp. 187–189, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Saiz, Y. Blanco, L. Sabater et al., “Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association,” Brain, vol. 131, no. 10, pp. 2553–2563, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. B. B. Murinson and J. B. Guarnaccia, “Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease,” Neurology, vol. 71, no. 24, pp. 1955–1958, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. D. P. Bogdanos and E. I. Rigopoulou, “Viral/self-mimicry and immunological cross-reactivity as a trigger of hepatic C virus associated autoimmune diabetes,” Diabetes Research and Clinical Practice, vol. 77, no. 1, pp. 155–156, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. W. F. Hickey, “Basic principles of immunological surveillance of the normal central nervous system,” GLIA, vol. 36, no. 2, pp. 118–124, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. C. F. Evans, M. S. Horwitz, M. V. Hobbs, and M. B. A. Oldstone, “Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease,” Journal of Experimental Medicine, vol. 184, no. 6, pp. 2371–2384, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Lauria, D. Pareyson, M. G. Pitzolu, and E. Bazzigaluppi, “Excellent response to steroid treatment in anti-GAD cerebellar ataxia,” Lancet Neurology, vol. 2, no. 10, pp. 634–635, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. M. C. Dalakas, “The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies,” Journal of Neurology, vol. 252, supplement 1, pp. I19–I25, 2005. View at Google Scholar · View at Scopus
  35. L. M. Levy, M. C. Dalakas, and M. K. Floeter, “The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of γ-aminobutyric acid,” Annals of Internal Medicine, vol. 131, no. 7, pp. 522–530, 1999. View at Google Scholar · View at Scopus
  36. S. de Vita, L. Quartuccio, and M. Fabris, “Rituximab in mixed cryoglobulinemia: increased experience and perspectives,” Digestive and Liver Disease, vol. 39, supplement 1, pp. S122–S128, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Cervetti, S. Mechelli, R. Riccioni, S. Galimberti, F. Caracciolo, and M. Petrini, “High efficacy of Rituximab in indolent HCV-related lymphoproliferative disorders asociated with systemic autoimmune diseases,” Clinical and Experimental Rheumatology, vol. 23, no. 6, pp. 877–880, 2005. View at Google Scholar · View at Scopus
  38. J. N. Acharya and V. H. Pacheco, “Neurologic complications of hepatitis C,” Neurologist, vol. 14, no. 3, pp. 151–156, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. L. E. Wilson, D. Widman, S. H. Dikman, and P. D. Gorevic, “Autoimmune disease complicating antiviral therapy for hepatitis C virus infection,” Seminars in Arthritis and Rheumatism, vol. 32, no. 3, pp. 163–173, 2002. View at Publisher · View at Google Scholar · View at Scopus